Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Scandinavian Journal of Urology and Nephrology|February 26, 2010
Primary bladder phaeochromocytoma diagnosed by a vetMarco Oderda, Federica Michelon, Micaela Appendino, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 29, 2022
Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysisAlessandro Rizzo, Veronica Mollica, Sara Merler, et al.
European Urology|December 9, 2009
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancerPaolo Gontero, Andreas Bohle, Per-Uno Malmstrom, et al.
Urologia|September 10, 2015
Urological consequences following renal transplantation: a review of the literatureAnna Palazzetti, Marco Oderda, Ettore Dalmasso, et al.
Clinical Genitourinary Cancer|November 2, 2015
Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient With Neurogenic BladderAnna Palazzetti, Marco Oderda, Marco Falcone, et al.
World Journal of Urology|October 2, 2023
Single-use digital flexible cystoscope for double J removal versus reusable instruments: a prospective, comparative study of functionality, risk of infection, and costsMarco Oderda, Anastasios Asimakopoulos, Valerio Batetta, et al.
Cancers|November 11, 2022
Urinary Zinc Loss Identifies Prostate Cancer PatientsMaria Grazia Maddalone, Marco Oderda, Giulio Mengozzi, et al.
Urology|November 30, 2016
Cell-cycle Progression-score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer PatientsMarco Oderda, Gabriele Cozzi, Lorenzo Daniele, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
Asian Journal of Andrology|March 13, 2015
Surgical management of hypogonadic patients with hypotrophic testicles and small penis: a novel, combined technique with an infrapubic approachMassimiliano Timpano, Marco Falcone, Franklin Kuehhas, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Scandinavian Journal of Urology and Nephrology|February 26, 2010
Primary bladder phaeochromocytoma diagnosed by a vetMarco Oderda, Federica Michelon, Micaela Appendino, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 29, 2022
Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysisAlessandro Rizzo, Veronica Mollica, Sara Merler, et al.
European Urology|December 9, 2009
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancerPaolo Gontero, Andreas Bohle, Per-Uno Malmstrom, et al.
Urologia|September 10, 2015
Urological consequences following renal transplantation: a review of the literatureAnna Palazzetti, Marco Oderda, Ettore Dalmasso, et al.
Clinical Genitourinary Cancer|November 2, 2015
Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient With Neurogenic BladderAnna Palazzetti, Marco Oderda, Marco Falcone, et al.
World Journal of Urology|October 2, 2023
Single-use digital flexible cystoscope for double J removal versus reusable instruments: a prospective, comparative study of functionality, risk of infection, and costsMarco Oderda, Anastasios Asimakopoulos, Valerio Batetta, et al.
Cancers|November 11, 2022
Urinary Zinc Loss Identifies Prostate Cancer PatientsMaria Grazia Maddalone, Marco Oderda, Giulio Mengozzi, et al.
Urology|November 30, 2016
Cell-cycle Progression-score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer PatientsMarco Oderda, Gabriele Cozzi, Lorenzo Daniele, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
Asian Journal of Andrology|March 13, 2015
Surgical management of hypogonadic patients with hypotrophic testicles and small penis: a novel, combined technique with an infrapubic approachMassimiliano Timpano, Marco Falcone, Franklin Kuehhas, et al.
Pageof 18